|
|
|
Transplant Statistics: Annual Report : Reference Tables
| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | ||
| Transplants | 2,126 | 2,171 | 2,297 | 2,340 | 2,361 | 2,342 | 2,294 | 2,347 | 2,187 | 2,197 | |
| Tx With Follow-up Immunosuppression Info | 1,773 | 1,832 | 1,907 | 1,909 | 1,895 | 1,914 | 1,878 | 1,961 | 1,743 | 1,754 | |
| Corticosteroids | Category Usage | 94.0% | 95.7% | 95.9% | 90.2% | 90.7% | 89.0% | 87.7% | 90.3% | 93.1% | 92.8% |
| Prednisone | 94.0% | 95.7% | 95.9% | 90.0% | 90.6% | 88.5% | 87.3% | 89.9% | 92.8% | 92.5% | |
| Methylprednisolone | 0.2% | 0.4% | 2.5% | 1.0% | 1.3% | 1.3% | 1.5% | 3.2% | 4.8% | 4.4% | |
| Cyclosporine | Category Usage | 97.5% | 99.0% | 98.2% | 89.3% | 82.2% | 85.0% | 82.9% | 78.4% | 81.9% | 77.7% |
| Cyclosporin | 97.3% | 98.9% | 97.2% | 82.1% | 1.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Sandimmmune | 0.2% | 0.6% | 2.7% | 7.1% | 42.6% | 19.5% | 12.4% | 10.4% | 8.0% | 5.0% | |
| Neoral | 0.0% | 0.1% | 0.3% | 0.7% | 42.1% | 66.2% | 71.3% | 68.7% | 74.5% | 69.2% | |
| Gengraf | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 5.2% | |
| Eon | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | |
| Tacrolimus | Category Usage | 2.4% | 1.1% | 1.8% | 3.6% | 10.1% | 15.1% | 17.7% | 24.5% | 26.9% | 30.0% |
| FK506 | 2.4% | 1.1% | 1.8% | 3.6% | 10.1% | 15.1% | 17.7% | 24.5% | 26.9% | 30.0% | |
| Antimetabolites | Category Usage | 95.8% | 96.5% | 95.4% | 89.7% | 88.1% | 90.3% | 90.0% | 90.3% | 86.2% | 90.9% |
| Azathioprine | 95.5% | 96.5% | 94.9% | 87.8% | 76.2% | 61.7% | 42.7% | 34.3% | 28.5% | 19.0% | |
| Mycophenolate mofetil | 0.6% | 0.2% | 0.6% | 2.9% | 16.9% | 32.5% | 51.2% | 64.2% | 66.9% | 78.9% | |
| Other | Category Usage | 1.6% | 2.0% | 1.8% | 1.8% | 2.0% | 1.0% | 1.0% | 1.3% | 3.2% | 5.3% |
| Rapamycin | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.1% | 0.4% | 2.5% | 4.8% | |
| Cytoxan | 1.6% | 2.0% | 1.8% | 1.7% | 2.0% | 1.0% | 0.9% | 1.0% | 0.7% | 0.7% | |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.